August 22, 2014 7:45 PM ET


Company Overview of Maxim Pharmaceuticals Inc.

Company Overview

As of January 4, 2006, Maxim Pharmaceuticals Inc. was acquired by EpiCept Corporation. Maxim Pharmaceuticals, Inc., a biopharmaceutical company, develops cancer therapeutics. Its lead drug candidate, Ceplene, is in a phase III clinical trial as a remission maintenance therapy for patients with acute myeloid leukemia, a form of adult leukemia. The company’s Apoptosis drug is under preclinical trial; and MX8899, which is in phase I and II clinical trials for oral mucositis and radiation dermatitis. Maxim also has Ceplene for chronic liver disease under phase I and phase II clinical trials. Ceplene prevents or reverses damage associated with oxidative stress, thereby protecting critical cells a...

8899 University Center Lane

Suite 400

San Diego, CA 92122

United States

Founded in 1954

32 Employees





Key Executives for Maxim Pharmaceuticals Inc.

Maxim Pharmaceuticals Inc. does not have any Key Executives recorded.

Maxim Pharmaceuticals Inc. Key Developments

EpiCept Corporation Together with its Wholly-Owned Subsidiaries Maxim Pharmaceuticals Inc. and Cytovia, Inc., Enter into a Second Amendment to Loan and Security Agreement with MidCap Funding III, LLC

EpiCept Corporation together with its wholly-owned subsidiaries Maxim Pharmaceuticals Inc. and Cytovia Inc., entered in to a second amendment to loan and security agreement with MidCap Funding III, LLC, as agent for the lenders. Under the amendment, the company will continue to make monthly payments of interest to the lender as per the loan and security agreement and one half of the cash that is subject to the security interest maintained by MidCap will be returned to the company upon the favorable stockholder vote to approve the final conditions to the closing of the merger. Any past defaults under the loan agreement have been waived and principal payments on the loan are scheduled to begin September 1, 2013 unless a restructuring of the loan has been executed.

Similar Private Companies By Industry

Company Name Region
Dynamis Therapeutics, Inc. United States
BioSavita, Inc. United States
Circe Biomedical, Inc. United States
Phage International, Inc. United States
Cadrus Therapeutics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Maxim Pharmaceuticals Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at